Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)-Reference-Cited by-同舟云学术

Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)

Published:2005-05 Issue:1-2 Volume:300 Page:146-159
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Böldicke Thomas,Weber Holger,Mueller Peter P.,Barleon Bernhard,Bernal Maria

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference25 articles.

1. A cancer gene therapy approach utilizing an anti-erb-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial;Alvarez;Clin. Cancer Res.,2000

2. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria;Biocca;Bio/Technology,1995

3. Anti-KDR scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (KDR/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood;Böldicke;Stem Cells,2001

4. Antisense-RNA regulation and RNA interference;Brantl;Biochim. Biophys. Acta,2002

5. Angiogenesis in cancer and other diseases;Carmeliet;Nature,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target;Antibodies;2024-03-18

2. Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy;Frontiers in Pharmacology;2023-12-05

3. Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology;BioDrugs;2020-04-16

4. A toolbox of nanobodies developed and validated for use as intrabodies and nanoscale immunolabels in mammalian brain neurons;eLife;2019-09-30

5. A toolbox of nanobodies developed and validated for diverse neuroscience research applications;2019-05-09